Operating profitability in branded pharmaceutical firms


Autoria(s): Charneca, Diogo Fernando Aurélio Semião
Contribuinte(s)

Ferreira, Leonor

Data(s)

14/03/2014

01/06/2013

Resumo

A Work Project, presented as part of the requirements for the Award of a Masters Degree in Management from the NOVA – School of Business and Economics

This work project focuses in operating profitability of branded pharmaceuticals, measured by return on assets (ROA). It gives insights about key ROA drivers, by breaking down this ratio into gross sales margin, assets turnover and operating risk. Data from consolidated financial statements of 26 US- and European-based firms for the period 2007-2011 is used in univariate and bivariate analyses. Results suggested that firm size and country-membership do not significantly correlate with ROA. However, differences between branded pharmaceuticals’ regions are explored and significant correlations are found between operating profitability and strategic choices variables, namely product portfolio diversification, growth choices and investment.

Identificador

http://hdl.handle.net/10362/11612

Idioma(s)

eng

Publicador

NSBE - UNL

Direitos

openAccess

Palavras-Chave #Operating profitability #Ratio analysis #Branded pharmaceuticals #US and Europe
Tipo

masterThesis